SINGAPORE: Embattled Cordlife Group said on Aug 15 that the international Association for the Advancement of Blood and Biotherapies (AABB) has withdrawn the company’s AABB accreditation for cord blood activities – collection, processing, storage and distribution.
This was after Cordlife provided an update to AABB at the organisation’s request that Singapore’s Health Ministry (MoH) had issued a notice to the cord blood bank barring it from collecting, testing and storing new cord blood for three months from June.
